Skip to content

Clinical trials

Phase 4 Schizophrenia trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20064
20081
20092
20101

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
University of Sao Paulo2
Ambulatório de Bipolaridade1
Hospital de Clinicas de Porto Alegre1
Janssen-Cilag Farmaceutica Ltda.1
Janssen-Cilag Ltd.1
Ortho-McNeil Janssen Scientific Affairs, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia12
Psychotic Disorders2
Mania1
Schizophrenia, Paranoid1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.